![](/wp-content/uploads/2024/04/Screenshot-2024-04-25-at-3.05.36%E2%80%AFPM.png)
$599
Viking, AZ, Sanofi, and Merck Q1 ’24 Earnings
Four cardiometabolic-related news items have been observed from Viking Therapeutics, AstraZeneca, Sanofi, and Merck. Below, FENIX provides highlights and insights for the respective news items.
Four cardiometabolic-related news items have been observed from Viking Therapeutics, AstraZeneca, Sanofi, and Merck. Below, FENIX provides highlights and insights for the respective news items.